About
CTI Life Sciences Fund makes venture capital investments in high quality emerging life science companies at the pre-clinical and clinical development stages.
Our main guiding principle is to catalyze, transform and invest in the future of life sciences across Canada, the U.S. and Europe. The Fund is driven by a complimentary management team providing deep scientific knowledge base, board management and governance experience, and business acumen.
Source: CTI Life Sciences Fund
Strategy
CTI Life Sciences Fund strategy revolves around the "Inception-2-Inflection" concept. We will invest from birthing new companies to more advanced-clinical-stage organizations.
Our compounded experiences are rooted in broad pharmaceutical R&D, astute business transactions and hands-on governance. We seek highly differentiated and scalable ideas, that we will chaperone forward to growth.
Source: CTI Life Sciences Fund
Industry Focus
Biotechnology
Year Founded
2006
Contact Info
Key Personnel
Dr. Shermaine Tilley Ph.D., MBA - Managing Partner
Mr. Ken Pastor - Managing Partner
Laurence Rulleau - Managing Partner